This project aims to support the development of a cross-platform smartphone application for the triage and monitoring of Covid-19 patients. The team plans to do so by leveraging sensors data collected with smartphones and the existing Health Readiness and Performance System (HRAPS) cloud for machine learning and data analytics. The developing technology will also apply to the longitudinal tracking of exposure to chemical and biological threats in military environments. For now, the technology will allow doctors and healthcare facilities to manage readmissions for Covid-19 patients better, intervene on patients before they become critical with potentially life-saving implications, and reduce the burden on emergency rooms and hospitals.

• Project details will not be shared at this time. For any inquiries, please use the contact us section on this site.

This project aims to design an emergency ventilator that could be built entirely with widely available off-the-shelf parts from hardware and auto parts stores. The design valued efficiency and simplicity in multiple areas.

• No specialized tools, computer programming, or electronics/manufacturing skills are required.
• The design can be built by one or two people in approximately one day.
• The total cost is roughly $350 in parts. 

In the basic configuration, the design supports a pressure-controlled constant mandatory ventilation mode (PC-CMV), with continuous independent control of positive inspiratory pressure (PIP), positive end-expiratory pressure (PEEP), and an inhale/exhale ratio selection of either 1:1 or 3:1. 

Support the manufacturing industry in upscaling the production of plastic nasal swabs that go into Covid-19 swab kits. Researchers teamed with Kimberly Clark, connected the company to Puritan Medical Diagnostics, and provided other "learning curve" support. The goal has been to support the manufacturers in soliciting key manufacturing expertise. The team has provided several key expert connections, so the companies can upscale their production more rapidly. Researchers have learned that the core U.S. manufacturers have the capacity to supply millions of swabs per week, but they still need to repurpose these to Covid-19 kits and break out of existing supply contracts for other supplies. Thus, the critical limitations are at the distribution level though sufficient materials exist. The effort is being handled by these manufacturers, and the team is on standby for further input as needed.